Intracranial Aneurysm Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Intracranial aneurysms affect an estimated 3-5% of the global population, with most remaining asymptomatic until they rupture or are discovered incidentally during imaging for unrelated conditions. The market covers the full care pathway, from diagnostic imaging modalities like CT angiography, MR angiography, and digital subtraction angiography to treatment devices including surgical clips, endovascular coils, flow diverters, and stent-assisted coiling systems. While market sizing varies across industry reports, consensus places the 2025 global market near $1.8 billion with a steady upward trajectory through the next decade.

• •Market valued at roughly $1.8 billion in 2025; projections range from $2.7 billion to $5.8 billion by 2030-2036
• •Includes diagnostic imaging equipment and interventional treatment devices for cerebral aneurysms
• •Covers both surgical and endovascular treatment modalities across hospital and ambulatory settings

The aging global population is a primary factor, as aneurysm prevalence increases significantly in adults over 55. Concurrently, the widespread adoption of high-resolution neuroimaging, driven by both routine screening and expanded access to CT and MRI, has led to more incidental aneurysm detections, expanding the addressable patient pool. Advances in minimally invasive endovascular techniques, including the development of newer-generation flow diverters and softer coil designs, have broadened the range of treatable aneurysms and reduced the need for open surgical clipping in many cases.

• •Aging demographics and rising aneurysm prevalence in older adult populations
• •Improved and more widely available neuroimaging leading to higher detection rates
• •Technological advances in endovascular devices making more complex aneurysms treatable

The market is commonly segmented by treatment type into surgical clipping, endovascular coiling, and flow diversion, with endovascular approaches capturing the largest and fastest-growing share due to their less invasive nature and favorable clinical outcomes for many aneurysm types. Product-level segmentation includes coils, flow diverters, embolic materials, microcatheters, and surgical clips, alongside diagnostic imaging systems. Geographically, North America holds the largest market share due to high healthcare spending, advanced hospital infrastructure, and strong adoption of new neurovascular technologies, while Asia-Pacific is expected to grow the fastest as diagnostic access improves across countries like China, India, and Japan.

• •North America leads in market share; Asia-Pacific is the fastest-growing regional segment
• •Endovascular treatments are overtaking surgical clipping as the dominant modality
• •Segments include coils, flow diverters, stents, surgical clips, and neuroimaging equipment

What are the recent trends and outlook?

A notable trend is the increasing use of flow-diverting stents for wide-necked and complex aneurysms that were previously difficult to treat with standard coiling, supported by growing clinical evidence. Regulatory and reimbursement dynamics continue to shape adoption rates, with new device approvals and expanded indications opening additional market opportunities. Looking ahead, continued investment in research and development, combined with rising global screening rates and expanding access to neurointerventional care in emerging markets, is expected to sustain the market's growth trajectory through the 2030s.

• •Flow-diverting stents are gaining share in the treatment of complex and wide-necked aneurysms
• •Advances in coil technology and bioactive embolic materials are improving procedural success rates
• •Expansion of neurointerventional capabilities in emerging markets is expected to broaden the global patient base